BioQuest Corp. Logo

BioQuest Corp.

BQST

(2.0)
Stock Price

1,00 USD

-427783.87% ROA

21.67% ROE

-44.17x PER

Market Cap.

5.857.452,00 USD

-28.17% DER

0% Yield

0% NPM

BioQuest Corp. Stock Analysis

BioQuest Corp. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

BioQuest Corp. Fundamental Stock Analysis
# Analysis Rating
1 ROE

The stock's ROE exceeds expectations (65.51%), revealing strong profitability and efficient use of shareholders' equity, making it an attractive investment opportunity.

2 PBV

With a remarkably low PBV ratio (-45.43x), the stock offers substantial upside potential at a bargain price.

3 DER

The stock has a minimal amount of debt (-42%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

4 Revenue Growth

With a track record of continuous revenue growth in the last three years, this company offers a promising investment opportunity

5 Net Profit Growth

This company's net profit has been consistently on the rise over the past three years, indicating a strong financial performance and making it an appealing investment opportunity.

6 ROA

The stock's ROA (-2150.89%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

7 Assets Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

8 Graham Number

The company's Graham number suggests that its stock price is overestimated, implying that it may not be a promising investment opportunity.

9 Dividend Growth

The company's dividend growth has shown no improvement in the past three years, making it a less attractive investment option for those seeking increasing returns.

10 Dividend

Investors should note the absence of dividends from the company in the last three years, indicating potential financial challenges.

11 Buffet Intrinsic Value

The company's stock presents a potential concern as it appears overvalued (0) by Warren Buffett's formula, indicating that its market price exceeds its estimated intrinsic value.

BioQuest Corp. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

BioQuest Corp. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Sell
3 RSI Buy
4 Stoch RSI Buy

BioQuest Corp. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

BioQuest Corp. Revenue
Year Revenue Growth
2012 0
2013 0 0%
2014 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%
2025 0 0%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

BioQuest Corp. Research and Development Expenses
Year Research and Development Expenses Growth
2012 0
2013 0 0%
2014 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%
2025 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

BioQuest Corp. General and Administrative Expenses
Year General and Administrative Expenses Growth
2012 0
2013 8.277 100%
2014 251.903 96.71%
2018 0 0%
2019 2 100%
2020 356.554 100%
2021 2.200.549 83.8%
2022 817.920 -169.04%
2023 198.688 -311.66%
2023 49 -405385.71%
2024 40 -25.64%
2025 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

BioQuest Corp. EBITDA
Year EBITDA Growth
2012 -2
2013 -7.629 99.97%
2014 113.028 106.75%
2018 -2.180 5284.77%
2019 -2.180 0%
2020 -356.554 99.39%
2021 -2.200.549 83.8%
2022 -817.920 -169.04%
2023 -198.688 -311.66%
2023 -49.060 -304.99%
2024 -34 -148566.67%
2025 -61.000 99.95%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

BioQuest Corp. Gross Profit
Year Gross Profit Growth
2012 -2
2013 -648 99.69%
2014 -648 0%
2018 0 0%
2019 0 0%
2020 -164 100%
2021 -1.408 88.35%
2022 -468 -201.5%
2023 0 0%
2023 0 0%
2024 0 0%
2025 0 0%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

BioQuest Corp. Net Profit
Year Net Profit Growth
2012 -2
2013 -8.277 99.98%
2014 -616.186 98.66%
2018 -2.175 -28230.39%
2019 -2.175 0%
2020 -361.504 99.4%
2021 -2.361.600 84.69%
2022 -721.408 -227.36%
2023 -693.716 -3.99%
2023 -140.664 -393.17%
2024 -123 -114260.98%
2025 -94.956 99.87%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

BioQuest Corp. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2012 0
2013 0 0%
2014 -23 100%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%
2025 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

BioQuest Corp. Free Cashflow
Year Free Cashflow Growth
2012 -4
2013 -7.629 99.95%
2014 -600.340 98.73%
2019 2 30017100%
2020 -124.834 100%
2021 -193.206 35.39%
2022 -116.720 -65.53%
2023 -53.509 -118.13%
2023 -18.585 -187.91%
2024 -62.712 70.36%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

BioQuest Corp. Operating Cashflow
Year Operating Cashflow Growth
2012 -2
2013 -7.629 99.97%
2014 -600.340 98.73%
2019 2 30017100%
2020 -124.834 100%
2021 -193.206 35.39%
2022 -116.720 -65.53%
2023 -53.509 -118.13%
2023 -18.585 -187.91%
2024 -62.712 70.36%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

BioQuest Corp. Capital Expenditure
Year Capital Expenditure Growth
2012 2
2013 0 0%
2014 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

BioQuest Corp. Equity
Year Equity Growth
2012 2.740
2013 9.023 69.63%
2014 875.203 98.97%
2019 -8.820 10022.94%
2020 -138.579 93.64%
2021 -1.769.541 92.17%
2022 -432.990 -308.68%
2023 -536.419 19.28%
2023 -553.654 3.11%
2024 -626.982 11.7%
2025 -650.721 3.65%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

BioQuest Corp. Assets
Year Assets Growth
2012 2.740
2013 9.124 69.97%
2014 889.903 98.97%
2019 0 0%
2020 166 100%
2021 17.097 99.03%
2022 33.540 49.03%
2023 14.955 -124.27%
2023 31 -48141.94%
2024 5.914 99.48%
2025 31 -18977.42%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

BioQuest Corp. Liabilities
Year Liabilities Growth
2012 0
2013 101 100%
2014 14.700 99.31%
2019 8.820 -66.67%
2020 138.745 93.64%
2021 1.786.638 92.23%
2022 466.530 -282.96%
2023 551.374 15.39%
2023 553.685 0.42%
2024 632.896 12.52%
2025 650.753 2.74%

BioQuest Corp. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0
Net Income per Share
-0.01
Price to Earning Ratio
-44.17x
Price To Sales Ratio
0x
POCF Ratio
-93.44
PFCF Ratio
-93.44
Price to Book Ratio
-9
EV to Sales
0
EV Over EBITDA
-61.52
EV to Operating CashFlow
-96.36
EV to FreeCashFlow
-96.36
Earnings Yield
-0.02
FreeCashFlow Yield
-0.01
Market Cap
0,01 Bil.
Enterprise Value
0,01 Bil.
Graham Number
0.12
Graham NetNet
-0.06

Income Statement Metrics

Net Income per Share
-0.01
Income Quality
0.51
ROE
0.22
Return On Assets
-4277.84
Return On Capital Employed
0.15
Net Income per EBT
1
EBT Per Ebit
1.35
Ebit per Revenue
0
Effective Tax Rate
0.79

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0
Operating Profit Margin
0
Pretax Profit Margin
0
Net Profit Margin
0

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0.01
Free CashFlow per Share
-0.01
Capex to Operating CashFlow
0
Capex to Revenue
0
Capex to Depreciation
0
Return on Invested Capital
0.08
Return on Tangible Assets
-4277.84
Days Sales Outstanding
0
Days Payables Outstanding
0
Days of Inventory on Hand
0
Receivables Turnover
0
Payables Turnover
0
Inventory Turnover
0
Capex per Share
0

Balance Sheet

Cash per Share
0,00
Book Value per Share
-0,06
Tangible Book Value per Share
-0.06
Shareholders Equity per Share
-0.06
Interest Debt per Share
0.02
Debt to Equity
-0.28
Debt to Assets
5912.9
Net Debt to EBITDA
-1.87
Current Ratio
0
Tangible Asset Value
0,00 Bil.
Net Current Asset Value
0,00 Bil.
Invested Capital
-650722
Working Capital
0,00 Bil.
Intangibles to Total Assets
0
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
0
Debt to Market Cap
0.03

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

BioQuest Corp. Dividends
Year Dividends Growth

BioQuest Corp. Profile

About BioQuest Corp.

BioQuest Corp. intends to acquire companies in green energy sector in the United States. The company was formerly known as Select-TV Solutions, Inc. and changed its name to BioQuest Corp. in November 2019. BioQuest Corp. was incorporated in 2011 and is based in Newport Beach, California.

CEO
Mr. Thomas C. Hemingway
Employee
4
Address
3700 Campus Drive
Newport Beach, 92660

BioQuest Corp. Executives & BODs

BioQuest Corp. Executives & BODs
# Name Age
1 Ms. Pamela A. Daily
Chief Marketing Officer
70
2 Mr. Jefferey Donnell
Chief Business Development Officer & Director
70
3 Mr. Thomas C. Hemingway
Chairman & Chief Executive Officer
70
4 Mr. David P. Noyes
Chief Financial Officer
70
5 Mr. Michael L. Krall
Chief Operating Officer, President & Director
70

BioQuest Corp. Competitors